* SANCUSO® (Granisetron Transdermal System) is indicated for the prevention of nausea and vomiting in patients receiving moderately and/or highly emetogenic chemotherapy
regimens of up to 5 consecutive days duration1
†Mechanically compromised cancer patients include those with oral and/or gastrointestinal impairment associated with chemotherapy, with or without radiation,2,3,7,8 or tumor burden,9,10 who may be unable to take or retain oral antiemetics.11
‡ SANCUSO is not indicated for radiation induced nausea and vomiting.
§ This offer is not valid for prescriptions under Medicare (including Medicare Advantage, Part A, B and D Plans), Medicaid, VA, DOD, TRICARE, CHAMPUS, or other federal or state healthcare programs (such as LIS). Kyowa Kirin, Inc., reserves the right to cancel or modify the program at any time. Unless otherwise indicated on submission form, Sancuso will be dispensed through select ASPN network pharmacy partners; available at participating pharmacies. This offer is not valid for prescriptions in Massachusetts or in any other state that does not permit copay reimbursement consistent with this program. Patients without commercial insurance are not eligible for this program. Offer expires January 31, 2017.